176 related articles for article (PubMed ID: 26769653)
1. Central administration of the anorexigenic peptide neuromedin U decreases alcohol intake and attenuates alcohol-induced reward in rodents.
Vallöf D; Ulenius L; Egecioglu E; Engel JA; Jerlhag E
Addict Biol; 2017 May; 22(3):640-651. PubMed ID: 26769653
[TBL] [Abstract][Full Text] [Related]
2. The Anorexigenic Peptide Neuromedin U (NMU) Attenuates Amphetamine-Induced Locomotor Stimulation, Accumbal Dopamine Release and Expression of Conditioned Place Preference in Mice.
Vallöf D; Vestlund J; Engel JA; Jerlhag E
PLoS One; 2016; 11(5):e0154477. PubMed ID: 27139195
[TBL] [Abstract][Full Text] [Related]
3. Brain region-specific neuromedin U signalling regulates alcohol-related behaviours and food intake in rodents.
Vallöf D; Kalafateli AL; Jerlhag E
Addict Biol; 2020 May; 25(3):e12764. PubMed ID: 31069918
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1 receptors within the nucleus of the solitary tract regulate alcohol-mediated behaviors in rodents.
Vallöf D; Vestlund J; Jerlhag E
Neuropharmacology; 2019 May; 149():124-132. PubMed ID: 30772374
[TBL] [Abstract][Full Text] [Related]
5. Activation of amylin receptors attenuates alcohol-mediated behaviours in rodents.
Kalafateli AL; Vallöf D; Jerlhag E
Addict Biol; 2019 May; 24(3):388-402. PubMed ID: 29405517
[TBL] [Abstract][Full Text] [Related]
6. Brain region specific glucagon-like peptide-1 receptors regulate alcohol-induced behaviors in rodents.
Vallöf D; Kalafateli AL; Jerlhag E
Psychoneuroendocrinology; 2019 May; 103():284-295. PubMed ID: 30771711
[TBL] [Abstract][Full Text] [Related]
7. Gut-brain axis and addictive disorders: A review with focus on alcohol and drugs of abuse.
Jerlhag E
Pharmacol Ther; 2019 Apr; 196():1-14. PubMed ID: 30439457
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic actions of neuromedin U.
Wren AM; Small CJ; Abbott CR; Jethwa PH; Kennedy AR; Murphy KG; Stanley SA; Zollner AN; Ghatei MA; Bloom SR
Endocrinology; 2002 Nov; 143(11):4227-34. PubMed ID: 12399416
[TBL] [Abstract][Full Text] [Related]
9. Central administration of neuromedin U suppresses food intake in chicks.
Kamisoyama H; Honda K; Saneyasu T; Sugahara K; Hasegawa S
Neurosci Lett; 2007 Jun; 420(1):1-5. PubMed ID: 17445984
[TBL] [Abstract][Full Text] [Related]
10. The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents.
Egecioglu E; Steensland P; Fredriksson I; Feltmann K; Engel JA; Jerlhag E
Psychoneuroendocrinology; 2013 Aug; 38(8):1259-70. PubMed ID: 23219472
[TBL] [Abstract][Full Text] [Related]
11. Comparison of feeding suppression by the anorexigenic hormones neuromedin U and neuromedin S in rats.
Nakahara K; Katayama T; Maruyama K; Ida T; Mori K; Miyazato M; Kangawa K; Murakami N
J Endocrinol; 2010 Nov; 207(2):185-93. PubMed ID: 20732934
[TBL] [Abstract][Full Text] [Related]
12. Alcohol-mediated behaviours and the gut-brain axis; with focus on glucagon-like peptide-1.
Jerlhag E
Brain Res; 2020 Jan; 1727():146562. PubMed ID: 31759971
[TBL] [Abstract][Full Text] [Related]
13. Regulation of motivation for food by neuromedin U in the paraventricular nucleus and the dorsal raphe nucleus.
McCue DL; Kasper JM; Hommel JD
Int J Obes (Lond); 2017 Jan; 41(1):120-128. PubMed ID: 27748746
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterisation of four cDNAs encoding neuromedin U (NMU) from the brain and gut of goldfish, and the inhibitory effect of a deduced NMU on food intake and locomotor activity.
Maruyama K; Konno N; Ishiguro K; Wakasugi T; Uchiyama M; Shioda S; Matsuda K
J Neuroendocrinol; 2008 Jan; 20(1):71-8. PubMed ID: 18081554
[TBL] [Abstract][Full Text] [Related]
15. Neuromedin U induces self-grooming in socially-stimulated mice.
Vestlund J; Kalafateli AL; Studer E; Westberg L; Jerlhag E
Neuropharmacology; 2020 Jan; 162():107818. PubMed ID: 31647973
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of neuromedin U actions in energy homeostasis and pituitary function.
Ivanov TR; Lawrence CB; Stanley PJ; Luckman SM
Endocrinology; 2002 Oct; 143(10):3813-21. PubMed ID: 12239092
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic potential of glucagon-like peptide-1 for persons with addictions based on findings from preclinical and clinical studies.
Jerlhag E
Front Pharmacol; 2023; 14():1063033. PubMed ID: 37063267
[TBL] [Abstract][Full Text] [Related]
18. Purification and identification of native forms of goldfish neuromedin U from brain and gut.
Maruyama K; Kaiya H; Miyazato M; Murakami N; Nakahara K; Matsuda K
Biochem Biophys Res Commun; 2019 Sep; 517(3):433-438. PubMed ID: 31376933
[TBL] [Abstract][Full Text] [Related]
19. A role for neuromedin U in stress response.
Hanada R; Nakazato M; Murakami N; Sakihara S; Yoshimatsu H; Toshinai K; Hanada T; Suda T; Kangawa K; Matsukura S; Sakata T
Biochem Biophys Res Commun; 2001 Nov; 289(1):225-8. PubMed ID: 11708803
[TBL] [Abstract][Full Text] [Related]
20. PEGylated neuromedin U-8 shows long-lasting anorectic activity and anti-obesity effect in mice by peripheral administration.
Masuda Y; Kumano S; Noguchi J; Sakamoto K; Inooka H; Ohtaki T
Peptides; 2017 Aug; 94():99-105. PubMed ID: 28400225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
